Breakthrough research shows diabetes medicine metformin may reduce age-related vision loss by 37%. Liverpool study offers ...

Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of ...

November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent ...

Diabetic retinopathy remains a leading cause of preventable vision loss, yet predicting which patients will experience disease progression remains challenging.

Review of screening retinal images for diabetic retinopathy by an artificial intelligence (AI) system demonstrated potential for significantly reducing the need for manual review with no loss in ...

A Johns Hopkins Children's Center study of children and youth with diabetes concludes that so-called autonomous artificial intelligence (AI) diabetic eye exams significantly increase completion rates ...

Please provide your email address to receive an email when new articles are posted on . It is a well-known fact that individuals with diabetes have an increased likelihood of developing ocular ...

Regular eye exams are important in detecting early signs of diabetic retinopathy to prevent vision loss. Since diabetic retinopathy doesn’t cause symptoms in its early stages, diagnostic testing can ...

Mangaluru: In a development marking an advance in diabetes screening, researchers from India and the US have developed an AI-based method that identif.

The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell ...